Rowe SE, Wagner NJ, Li L, Beam JE, Wilkinson AD, Radlinski LC, Zhang Q, Miao EA, Conlon BP (2020) Reactive oxygen species induce antibiotic tolerance during systemic Staphylococcus aureus infection. Nat Microbiol 5:282–290. https://doi.org/10.1038/s41564-019-0627-y
Ma XX, Sun DD, Wang S, Wang ML, Li M, Shang H, Wang EH, Luo EJ (2011) Nasal carriage of methicillin-resistant Staphylococcus aureus among preclinical medical students: epidemiologic and molecular characteristics of methicillin-resistant S. aureus clones. Diagn Microbiol Infect Dis 70:22–30. https://doi.org/10.1016/j.diagmicrobio.2010.12.004
John J Jr (2020) The treatment of resistant staphylococcal infections. F1000Res 9. https://doi.org/10.12688/f1000research.17718.1
Diaz R, Afreixo V, Ramalheira E, Rodrigues C, Gago B (2018) Evaluation of vancomycin MIC creep in methicillin-resistant Staphylococcus aureus infections-a systematic review and meta-analysis. Clin Microbiol Infect 24:97–104. https://doi.org/10.1016/j.cmi.2017.06.017
McGuinness WA, Malachowa N, DeLeo FR (2017) Vancomycin Resistance in Staphylococcus aureus. Yale J Biol Med 90:269–281
PubMed PubMed Central Google Scholar
Smith JR, Barber KE, Hallesy J, Raut A, Rybak MJ (2015) Telavancin demonstrates activity against methicillin-resistant Staphylococcus aureus isolates with reduced susceptibility to vancomycin, daptomycin, and linezolid in broth microdilution MIC and one-compartment pharmacokinetic/pharmacodynamic models. Antimicrob Agents Chemother 59:5529–5534. https://doi.org/10.1128/aac.00773-15
Article PubMed PubMed Central Google Scholar
Ozmen Capin BB, Tekeli A, Karahan ZC (2020) Evaluation of the Presence and Characterization of Vancomycin-Intermediate and Heterogeneous Vancomycin-Intermediate Level Resistance Among Bloodstream Isolates of Methicillin-Resistant Staphylococcus aureus. Microb Drug Resist 26:238–244. https://doi.org/10.1089/mdr.2019.0178
Hines KM, Shen T, Ashford NK, Waalkes A, Penewit K, Holmes EA, McLean K, Salipante SJ, Werth BJ, Xu L (2020) Occurrence of cross-resistance and β-lactam seesaw effect in glycopeptide-, lipopeptide- and lipoglycopeptide-resistant MRSA correlates with membrane phosphatidylglycerol levels. J Antimicrob Chemother 75:1182–1186. https://doi.org/10.1093/jac/dkz562
Article PubMed PubMed Central Google Scholar
Hiramatsu K, Aritaka N, Hanaki H, Kawasaki S, Hosoda Y, Hori S, Fukuchi Y, Kobayashi I (1997) Dissemination in Japanese hospitals of strains of Staphylococcus aureus heterogeneously resistant to vancomycin. Lancet 350:1670–1673. https://doi.org/10.1016/s0140-6736(97)07324-8
Shariati A, Dadashi M, Moghadam MT, van Belkum A, Yaslianifard S, Darban-Sarokhalil D (2020) Global prevalence and distribution of vancomycin resistant, vancomycin intermediate and heterogeneously vancomycin intermediate Staphylococcus aureus clinical isolates: a systematic review and meta-analysis. Sci Rep 10:12689. https://doi.org/10.1038/s41598-020-69058-z
Article PubMed PubMed Central Google Scholar
Cui L, Ma X, Sato K, Okuma K, Tenover FC, Mamizuka EM, Gemmell CG, Kim MN, Ploy MC, El-Solh N, Ferraz V, Hiramatsu K (2003) Cell wall thickening is a common feature of vancomycin resistance in Staphylococcus aureus. J Clin Microbiol 41:5–14. https://doi.org/10.1128/jcm.41.1.5-14.2003
Article PubMed PubMed Central Google Scholar
Hanaki H, Kuwahara-Arai K, Boyle-Vavra S, Daum RS, Labischinski H, Hiramatsu K (1998) Activated cell-wall synthesis is associated with vancomycin resistance in methicillin-resistant Staphylococcus aureus clinical strains Mu3 and Mu50. J Antimicrob Chemother 42:199–209. https://doi.org/10.1093/jac/42.2.199
Sieradzki K, Tomasz A (1999) Gradual alterations in cell wall structure and metabolism in vancomycin-resistant mutants of Staphylococcus aureus. J Bacteriol 181:7566–7570. https://doi.org/10.1128/jb.181.24.7566-7570.1999
Article PubMed PubMed Central Google Scholar
Nöldeke ER, Muckenfuss LM, Niemann V, Müller A, Störk E, Zocher G, Schneider T, Stehle T (2018) Author Correction: Structural basis of cell wall peptidoglycan amidation by the GatD/MurT complex of Staphylococcus aureus. Sci Rep 8:18073. https://doi.org/10.1038/s41598-018-37082-9
Article PubMed PubMed Central Google Scholar
Navratna V, Nadig S, Sood V, Prasad K, Arakere G, Gopal B (2010) Molecular basis for the role of Staphylococcus aureus penicillin binding protein 4 in antimicrobial resistance. J Bacteriol 192:134–144. https://doi.org/10.1128/jb.00822-09
Cui L, Iwamoto A, Lian JQ, Neoh HM, Maruyama T, Horikawa Y, Hiramatsu K (2006) Novel mechanism of antibiotic resistance originating in vancomycin-intermediate Staphylococcus aureus. Antimicrob Agents Chemother 50:428–438. https://doi.org/10.1128/aac.50.2.428-438.2006
Article PubMed PubMed Central Google Scholar
Chen H, Liu Y, Zhao C, Xiao D, Zhang J, Zhang F, Chen M, Wang H (2013) Comparative proteomics-based identification of genes associated with glycopeptide resistance in clinically derived heterogeneous vancomycin-intermediate Staphylococcus aureus strains. PloS One 8:e66880. https://doi.org/10.1371/journal.pone.0066880
Article PubMed PubMed Central Google Scholar
Xu J, Pang L, Ma XX, Hu J, Tian Y, Yang YL, Sun DD (2018) Phenotypic and Molecular Characterisation of Staphylococcus Aureus with Reduced Vancomycin Susceptibility Derivated in Vitro. Open Med (Wars) 13:475–486. https://doi.org/10.1515/med-2018-0071
G HJ (2004) Bergey's Manual of Determinative Bacteriology, 9th edn. Williams and Wilkins, Baltimore, pp 178–711
Meziane-Cherif D, Stogios PJ, Evdokimova E, Savchenko A, Courvalin P (2014) Structural basis for the evolution of vancomycin resistance D,D-peptidases. Proc Natl Acad Sci USA 111:5872–5877. https://doi.org/10.1073/pnas.1402259111
Article PubMed PubMed Central Google Scholar
Gorrie C, Higgs C, Carter G, Stinear TP, Howden B (2019) Genomics of vancomycin-resistant Enterococcus faecium. Microb Genom 5. https://doi.org/10.1099/mgen.0.000283
García-Solache M, Rice LB (2019) The Enterococcus: a Model of Adaptability to Its Environment. Clin Microbiol Rev 32. https://doi.org/10.1128/cmr.00058-18
Nguyen MT, Matsuo M, Niemann S, Herrmann M, Götz F (2020) Lipoproteins in Gram-Positive Bacteria: Abundance, Function. Fitness Front Microbiol 11:582582. https://doi.org/10.3389/fmicb.2020.582582
Stamsås GA, Restelli M, Ducret A, Freton C, Garcia PS, Håvarstein LS, Straume D, Grangeasse C, Kjos M (2020) A CozE Homolog Contributes to Cell Size Homeostasis of Streptococcus pneumoniae. mBio:11. https://doi.org/10.1128/mBio.02461-20
Mueller EA, Levin PA (2020) Bacterial Cell Wall Quality Control during Environmental Stress. mBio:11. https://doi.org/10.1128/mBio.02456-20
Vollmer W, Blanot D, de Pedro MA (2008) Peptidoglycan structure and architecture. FEMS Microbiol Rev 32:149–167. https://doi.org/10.1111/j.1574-6976.2007.00094.x
Dramsi S, Magnet S, Davison S, Arthur M (2008) Covalent attachment of proteins to peptidoglycan. FEMS Microbiol Rev 32:307–320. https://doi.org/10.1111/j.1574-6976.2008.00102.x
Neuhaus FC, Baddiley J (2003) A continuum of anionic charge: structures and functions of D-alanyl-teichoic acids in gram-positive bacteria. Microbiol Mol Biol Rev 67:686–723. https://doi.org/10.1128/mmbr.67.4.686-723.2003
Article PubMed PubMed Central Google Scholar
Okano A, Nakayama A, Schammel AW, Boger DL (2014) Total synthesis of [Ψ[C(═NH)NH]Tpg(4)]vancomycin and its (4-chlorobiphenyl)methyl derivative: impact of peripheral modifications on vancomycin analogues redesigned for dual D-Ala-D-Ala and D-Ala-D-Lac binding. J Am Chem Soc 136:13522–13525. https://doi.org/10.1021/ja507009a
Article PubMed PubMed Central Google Scholar
Bartlett AH, Park PW (2010) Proteoglycans in host-pathogen interactions: molecular mechanisms and therapeutic implications. Expert Rev Mol Med 12:e5. https://doi.org/10.1017/s1462399409001367
Article PubMed PubMed Central Google Scholar
Taylor KR, Gallo RL (2006) Glycosaminoglycans and their proteoglycans: host-associated molecular patterns for initiation and modulation of inflammation. FASEB J 20:9–22. https://doi.org/10.1096/fj.05-4682rev
Aquino RS, Park PW (2016) Glycosaminoglycans and infection. Front Biosci (Landmark Ed) 21:1260–1277. https://doi.org/10.2741/4455
Warraich AA, Mohammed AR, Perrie Y, Hussain M, Gibson H, Rahman A (2020) Evaluation of anti-biofilm activity of acidic amino acids and synergy with ciprofloxacin on Staphylococcus aureus biofilms. Sci Rep 10:9021. https://doi.org/10.1038/s41598-020-66082-x
Article PubMed PubMed Central Google Scholar
Cai L, Tong J, Zhang Z, Zhang Y, Jiang L, Hou X, Zhang H (2020) Staphylococcus aureus-induced proteomic changes in the mammary tissue of rats: A TMT-based study. PloS One 15:e0231168. https://doi.org/10.1371/journal.pone.0231168
Article PubMed PubMed Central Google Scholar
Sonkar A, Shukla H, Shukla R, Kalita J, Pandey T, Tripathi T (2017) UDP-N-Acetylglucosamine enolpyruvyl transferase (MurA) of Acinetobacter baumannii (AbMurA): Structural and functional properties. Int J Biol Macromol 97:106–114. https://doi.org/10.1016/j.ijbiomac.2016.12.082
Bibek GC, Sahukhal GS, Elasri MO (2019) Role of the msaABCR Operon in Cell Wall Biosynthesis, Autolysis, Integrity, and Antibiotic Resistance in Staphylococcus aureus. Antimicrob Agents Chemother 63. https://doi.org/10.1128/aac.00680-19
Falagas ME, Athanasaki F, Voulgaris GL, Triarides NA, Vardakas KZ (2019) Resistance to fosfomycin: Mechanisms, Frequency and Clinical Consequences. Int J Antimicrob Agents 53:22–28. https://doi.org/10.1016/j.ijantimicag.2018.09.013
Silver LL (2017) Fosfomycin: Mechanism and Resistance. Cold Spring Harb Perspect Med 7. https://doi.org/10.1101/cshperspect.a025262
Schilcher K, Horswill AR (2020) Staphylococcal Biofilm Development: Structure, Regulation, and Treatment Strategies. Microbiol Mol Biol Rev 84. https://doi.org/10.1128/mmbr.00026-19
Sabat A, Melles DC, Martirosian G, Grundmann H, van Belkum A, Hryniewicz W (2006) Distribution of the serine-aspartate repeat protein-encoding sdr genes among nasal-carriage and invasive Staphylococcus aureus strains. J Clin Microbiol 44:1135–1138. https://doi.org/10.1128/jcm.44.3.1135-1138.2006
Comments (0)